# Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

> **NCT07516418** · PHASE1 · RECRUITING · sponsor: **Sanofi** · enrollment: 570 (estimated)

## Conditions studied

- Respiratory Syncytial Virus (RSV)
- Influenza A(H5N1)

## Interventions

- **BIOLOGICAL:** H5 Flu Investigational Medical Product (IMP) 1
- **BIOLOGICAL:** H5 Flu IMP 2
- **BIOLOGICAL:** H5 Flu IMP 3
- **BIOLOGICAL:** RSV IMP 4
- **BIOLOGICAL:** RSV IMP 5
- **BIOLOGICAL:** RSV IMP 6
- **BIOLOGICAL:** H5 Flu IMP 7
- **BIOLOGICAL:** H5 Flu IMP 8
- **BIOLOGICAL:** H5 Flu IMP 9
- **BIOLOGICAL:** H5 Flu IMP 10
- **BIOLOGICAL:** H5 Flu IMP 11
- **BIOLOGICAL:** H5 Flu IMP 12

## Key facts

- **NCT ID:** NCT07516418
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2027-04-04
- **Final completion:** 2027-04-04
- **Target enrollment:** 570 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516418, "Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07516418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*